Abstract
The present invention relates to crystalline form of 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl]sulfinyl]-1H–benzimidazole sodium salt represented by the following structural formula-1a, which is referred to as Rabeprazole sodium.
Formula-1a
The present invention also relates to a process for the preparation of crystalline form of Rabeprazole sodium.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center, Hyderabad, India, Srinivasan Thirumalai Rajan, Seetharama Sarma Peri, Thirupathi Tatikonda., "Process for the preparation of crystalline form of 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl]sulfinyl]-1H–benzimidazole sodium salt thereof", Technical Disclosure Commons, ()
https://www.tdcommons.org/dpubs_series/8531